1-(1-Benzothiophen-4-yl)piperazine Hydrochloride CAS 913614-18-3 Mama>98.0% (HPLC) Brexpiprazole Intermediate Factory

Fa'amatalaga Puupuu:

1-(1-Benzothiophen-4-yl) piperazine Hydrochloride

CAS: 913614-18-3

Mama: >99.0% (HPLC)

Fa'aaliga: Pa'epa'e i le Pa'epa'e Pa'epa'e

Vaitaimi ole Brexpiprazole (CAS: 913611-97-9)

E-Mail: alvin@ruifuchem.com


Fa'amatalaga Oloa

Oloa Fa'atatau

Faailoga o oloa

Fa'amatalaga:

Meatotino tau vailaau:

Igoa Vailaau 1-(1-Benzothiophen-4-yl) piperazine Hydrochloride
Synonyms Brexpiprazole Intermediate 2;1-Benzo[b]thien-4-yl-Piperazine Hydrochloride;1-Benzo[b]thien-4-ylpiperazine Monohydrochloride
Numera CAS 913614-18-3
CAT Numera RF-PI1034
Tulaga Fa'asoa I Fa'atauga, Gaosiga Gafatia 100MT/Tausaga
Fuafua mole C12H15ClN2S
Molecular Weight 254.7789
Fa'ailoga Ruifu Chemical

Fa'amatalaga:

Aitema Fa'amatalaga
Fa'aaliga Pa'epa'e i le Pa'epa'e Pa'epa'e
Fa'ailoaga Taimi fa'atumauina o le fa'ata'ita'iga e fa'atatau i le tulaga fa'asino
Mama / Suʻesuʻega Metotia >99.0% (HPLC)
Ma'imau ile Fa'amago <0.50%
Vai (KF) <0.50%
Toega i luga o le mumu <0.20%
Mea Fa'atatau (HPLC)
So'o se Fa'aleaga Ta'ito'atasi <0.50%
Aofa'i Fa'aleaga <1.00%
Alaleo Infrared E tusa ai ma le Fauga
Proton NMR Alaleo E tusa ai ma le Fauga
Tulaga Su'ega Enterprise Standard
Fa'aoga Vaitaimi ole Brexpiprazole (CAS: 913611-97-9)

Paket & Teuina:

afifi: Fagu, ato pepa alumini, 25kg/Kati Pusa, pe tusa ai ma manaoga o tagata faatau

Tulaga teuina:Teu i totonu o pusa faʻamaufaʻailoga i se nofoaga malulu ma mago;Puipui mai le malamalama ma le susu

Tulaga lelei:

1

FAQ:

Talosaga:

1-(1-Benzothiophen-4-yl) piperazine Hydrochloride (CAS: 913614-18-3) o se vaeluaga ole Brexpiprazole (CAS: 913611-97-9).Brexpiprazole o se ituaiga atypical antipsychotic.O le dopamine D2 o le vaega ole agonist.I le avea ai ma se tala fou o le serotonin-dopamine, e mafai ona faʻaaogaina mo togafitiga o le schizophrenia, ma mo togafitiga faʻaopoopo mo le atuatuvale.E mafai foi ona maua ai le aoga ma le gafatia i luga o togafitiga faʻapipiʻi faʻapipiʻi mo le maʻi faʻavaivaia tele (MDD).O le vailaʻau o loʻo faʻaalia se talaaga faʻapitoa faʻafomaʻi, galue o se vaega o le agonist o le serotonin 5-HT1A ma le dopamine D2 faʻafeiloaʻi ma o se faʻataʻitaʻiga atoa o le 5-HT2A ma le noradrenaline α1B / 2C receptors, faʻatasi ai ma le tutusa o le subnanomolar binding affinity.O le vailaʻau, lea na atiaʻe e Otsuka ma Lundbeck, na faʻamaonia i le 2015 e le FDA mo togafitiga o le schizophrenia ma o se togafitiga faʻaopoopo mo le atuatuvale.

Tusi lau savali iinei ma lafo mai ia i matou